- Tissue
- Hard palate, salivary gland
- Disease
- Hard palate mucoepidermoid carcinoma
- Metastatic site
- Primary tumor site (hard palate)
- Synonyms
- University of Michigan-Human Mucoepidermoid Carcinoma-3B
Documents
UM-HMC-3B
Cell line · Product number 305715
Customization / Recommendations
- UM-HMC-3BCell line€0.00
Recommended (freshest lot)
01General information
- Description
UM-HMC-3B is a human mucoepidermoid carcinoma cell line established from a primary mucoepidermoid carcinoma of the hard palate salivary glands of a 73-year-old Caucasian female patient. The line is is part of the University of Michigan Human Mucoepidermoid Carcinoma (UM-HMC) panel. Like UM-HMC-1, UM-HMC-3B harbors the CRTC1-MAML2 gene fusion (MECT1-MAML2), the oncogenic driver in the majority of mucoepidermoid carcinomas, which results from a t(11;19)(q21;p13) translocation and drives CREB and Notch pathway activation.
UM-HMC-3B is applicable in studies of hard palate and salivary gland mucoepidermoid carcinoma biology, CRTC1-MAML2 signalling, and comparative analyses with other UM-HMC panel lines. Together with UM-HMC-1 and other panel members, UM-HMC-3B enables identification of common and divergent molecular features across mucoepidermoid carcinomas of different anatomical sites, ages, and genders. It is also suitable for drug sensitivity assays targeting fusion oncoproteins and downstream CREB/Notch effectors.
- Tissue
- Hard palate, salivary gland
- Disease
- Hard palate mucoepidermoid carcinoma
- Metastatic site
- Primary tumor site (hard palate)
- Applications
- Salivary gland carcinoma research; CRTC1-MAML2 fusion biology; hard palate MEC biology; CREB/Notch pathway; comparative UM-HMC panel studies; drug sensitivity assays
- Synonyms
- University of Michigan-Human Mucoepidermoid Carcinoma-3B
02Classification
- Organism
- Human
- Sex
- Female
- Growth properties
- Adherent
- GMO status
- Non-GMO
- GMO status details
- No genetic modification; somatic CRTC1-MAML2 fusion acquired during tumor development
- Biosafety level
- 1
03Characteristics
- Morphology
- Epithelial-like
- Cell type
- Epithelial cells
- Doubling time
- approx. 24 to 48 hours
04Identifiers
- Citation
- UM-HMC-3B (Cytion catalog number 305715)
- NCBI TaxID
- 9606
- Cellosaurus
- CVCL_Y472
05Expression and susceptibility
- Mutational profile
- Mutation: Gene fusion, CRTC1 + HGNC, MAML2, Name(s)=CRTC1-MAML2, MECT1-MAML2.
06Handling and culture
- Culture medium
- DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
- Incubation atmosphere
37°C, 5% CO2, humidified atmosphere.
- Supplements
- Supplement the medium with 10% FBS
- Dissociation reagent
- Accutase
- Subculturing
- Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium.
- Split ratio
- 1 to 5
- Seeding density
- 1 to 3 × 10⁴ cells/cm²
- Fluid renewal
- Every 2 to 3 days
- Thawing and culturing
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.
Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.
Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
07Quality control and cryopreservation
- Sterility
Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.
To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.
- Freeze medium
- As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
- Storage conditions
For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.
- Shipping conditions
Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
08Donor
- Donor age
- 73 years
- Ethnicity
- Caucasian
09Legal and safety
- Safety precautions
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments.
- Disclaimer
- Our cells are provided for in vitro laboratory research purposes exclusively and are not intended for clinical or diagnostic use, nor are they to be administered to humans or used for veterinary purposes. Users must adhere to all applicable guidelines and regulations for the handling and use of these cells in a research setting.
- Warranty
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Material Transfer Agreement required
- Yes


